THE CLINICAL PHARMACOKINETICS AND TOLERANCE OF ENOXACIN IN HEALTHY-VOLUNTEERS

被引：56

作者：

WOLF, R

EBERL, R

DUNKY, A

MERTZ, N

CHANG, T

GOULET, JR

LATTS, J

机构：

[1] KRANKENHAUS LAINZ,A-1130 VIENNA,AUSTRIA

[2] WARNER LAMBERT PARKE DAVIS,PHARMACEUT RES,ANN ARBOR,MI 48105

来源：

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY | 1984年 / 14卷

关键词：

D O I：

10.1093/jac/14.suppl_C.63

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

引用

收藏

页码：63 / 69

页数：7

相关论文

共 5 条

[1] INVITRO ACTIVITY OF CI-919 (AT-2266), AN ORAL ANTI-PSEUDONOMAL COMPOUND
CHARTRAND, SA
SCRIBNER, RK
WEBER, AH
WELCH, DF
MARKS, MI
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1983, 23 (05) : 658 - 663
[2] INVITRO AND INVIVO ANTI-BACTERIAL ACTIVITY OF AT-2266
KOUNO, K
INOUE, M
MITSUHASHI, S
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1983, 24 (01) : 78 - 84
[3] ACTIVITY OF AT-2266 COMPARED WITH THOSE OF NORFLOXACIN, PIPEMIDIC ACID, NALIDIXIC-ACID, AND GENTAMICIN AGAINST VARIOUS EXPERIMENTAL INFECTIONS IN MICE
NAKAMURA, S
NAKATA, K
KATAE, H
MINAMI, A
KASHIMOTO, S
YAMAGISHI, J
TAKASE, Y
SHIMIZU, M
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1983, 23 (05) : 742 - 749
[4] INVITRO ANTI-BACTERIAL PROPERTIES OF AT-2266, A NEW PYRIDONECARBOXYLIC ACID
NAKAMURA, S
MINAMI, A
KATAE, H
INOUE, S
YAMAGISHI, J
TAKASE, Y
SHIMIZU, M
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1983, 23 (05) : 641 - 648
[5] PHARMACOKINETICS AND TOLERANCE OF ENOXACIN IN HEALTHY-VOLUNTEERS ADMINISTERED AT A DOSAGE OF 400-MG TWICE DAILY FOR 14 DAYS
TSUEI, SE
DARRAGH, AS
BRICK, I
[J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1984, 14 : 71 - 74